Kronos Bio (KRON US)

Analysis

Health Care • United States

Kronos Bio, Inc. operates as a biotechnology company. The Company discovers and develops therapies that modulate historically recalcitrant cancer targets. Kronos Bio serves customers in worldwide.

Refresh

Focused

No publications yet

Add Kronos Bio to your Watchlist to get alerts on new publications

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00